These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24564960)

  • 1. Association between PADI4 gene polymorphisms and anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis in a large Chinese Han cohort.
    Du Y; Liu X; Guo JP; Liu X; Li R; Zhao Y; Liu X; Li MH; Li ZG
    Clin Exp Rheumatol; 2014; 32(3):377-82. PubMed ID: 24564960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
    Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
    Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population.
    Chen R; Wei Y; Cai Q; Duan S; Ren D; Shen J; He D; Fang M; Lv K; Cheng N; Sun S
    Rheumatol Int; 2011 Dec; 31(12):1631-4. PubMed ID: 20563870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis.
    Cheng J; Zhang H; Zhuang C; Liu R
    J Rheumatol; 2012 Jun; 39(6):1159-65. PubMed ID: 22505706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.
    Too CL; Murad S; Dhaliwal JS; Larsson P; Jiang X; Ding B; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Res Ther; 2012 Nov; 14(6):R250. PubMed ID: 23164236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
    Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
    Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study.
    Suzuki T; Ikari K; Yano K; Inoue E; Toyama Y; Taniguchi A; Yamanaka H; Momohara S
    PLoS One; 2013; 8(4):e61045. PubMed ID: 23577190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.
    Burr ML; Naseem H; Hinks A; Eyre S; Gibbons LJ; Bowes J; Wilson AG; Maxwell J; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Thomson W; Worthington J; ; ; Barton A
    Ann Rheum Dis; 2010 Apr; 69(4):666-70. PubMed ID: 19470526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
    Zavala-Cerna MG; Gonzalez-Montoya NG; Nava A; Gamez-Nava JI; Moran-Moguel MC; Rosales-Gomez RC; Gutierrez-Rubio SA; Sanchez-Corona J; Gonzalez-Lopez L; Davalos-Rodriguez IP; Salazar-Paramo M
    Clin Dev Immunol; 2013; 2013():383681. PubMed ID: 24454473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic Analysis of Genes PADI4 (rs2240340, rs1748033) and HLA-DRB1 (rs2395175) in Arthritis Patients in Pakistani Population.
    Bashir K; Chaudhary A; Aslam M; Fatima I; Sarwar R
    Biochem Genet; 2024 Jun; 62(3):1840-1856. PubMed ID: 37751115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies.
    Faragó B; Talián GC; Maász A; Magyari L; Horvatovich K; Kovács B; Cserép V; Kisfali P; Kiss CG; Czirják L; Melegh B
    Clin Exp Rheumatol; 2007; 25(4):523-8. PubMed ID: 17888206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.
    Ceccarelli F; D'Alfonso S; Perricone C; Carlomagno Y; Alessandri C; Croia C; Barizzone N; Montecucco C; Galeazzi M; Sebastiani GD; Minisola G; Fiocco U; Valesini G
    Clin Exp Rheumatol; 2012; 30(6):939-42. PubMed ID: 22992305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis.
    Ciesla M; Kolarz B; Darmochwal-Kolarz D
    Sci Rep; 2022 Jul; 12(1):11882. PubMed ID: 35831381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of single nucleotide polymorphisms (SNPs) of PADI4 gene with rheumatoid arthritis (RA) in Indian population.
    Panati K; Pal S; Rao KV; Reddy VD
    Genes Genet Syst; 2012; 87(3):191-6. PubMed ID: 22976394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP1, PTPN22 and PADI4 gene polymorphisms and rheumatoid arthritis in ACPA-positive Singaporean Chinese.
    Goh LL; Yong MY; See WQ; Chee EYW; Lim PQ; Koh ET; Leong KP;
    Rheumatol Int; 2017 Aug; 37(8):1295-1302. PubMed ID: 28653215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Massarenti L; Enevold C; Damgaard D; Ødum N; Garred P; Frisch M; Shelef MA; Jacobsen S; Nielsen CH
    Front Immunol; 2021; 12():707690. PubMed ID: 34733271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.